HEALTH NEWS4 years ago
Covaxin 77.8% effective in phase 3 trial data: Sources
According to data from Phase III trials conducted on 25,800 participants across India, the Covaxin is 77.8 per cent effective in protecting against COVID-19. According to...
Recent Comments